MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Profile of miRNA expression in CSF of Parkinson’s disease identifies miR-409-3p regulating the apoptosis of dopamine neurons

    X.L Tan, J.Q Tan, F.Y Ming, LL. Lv, H.N Zhang, B.S Tang, W.Q Yan, RR. Bai, X.K Peng, Q.L Xiao, C.Y Wang (Changsha, China)

    Objective: To improve the precise diagnosis of PD at early stage requires more feasible and objective methods. MicroRNA (miRNA) was believed to be a potential…
  • MDS Virtual Congress 2020

    Quantification of 123I-ioflupane Striatal Uptake and Individual Patient Diagnostic Predictions: Degenerative Parkinson’s disease, Non-Degenerative Parkinsonism and Tremor Disorders

    N. Heng, T. Gilbertson, M. Muqit, D. Steele (Dundee, United Kingdom)

    Objective: To develop a fully automated quantitative method to analyse routinely acquired 123I-ioflupane (DaTSCAN) data to aid diagnostic predictions in patients with Parkinson’s disease, non-degenerative…
  • MDS Virtual Congress 2020

    Retinal Pathology in Parkinson’s Disease: A Longitudinal Study with Optical Coherence Tomography

    F. Euler, D. Batra, J. Kassubek, E. Pinkhardt (Ulm, Germany)

    Objective: The aim of this study was to find retinal pathology in Parkinson’s disease (PD) via Optical Coherence Tomography (OCT) that deteriorates over time, as…
  • MDS Virtual Congress 2020

    In vivo markers of anxiety in drug-naïve Parkinson’s disease

    H. Wilson, E. de Natale, M. Politis (London, United Kingdom)

    Objective: To investigate imaging and CSF markers of disease pathology associated with anxiety in drug-naïve idiopathic Parkinson’s disease (PD) patients. Background: Anxiety is a frequent…
  • MDS Virtual Congress 2020

    Subclinical cardiac autonomic dysfunction in patients with Parkinson’s disease: A pilot study

    T.N Sathyaprabha, G. Inbaraj, N. Kuravatti, M.R Rukmani, B.S Krishnaprasad, R. Ravi, K. Mrudula, P. John (Bangalore, India)

    Objective: The aim of this study is to assess cardiac autonomic dysfunction in Parkinson’s disease (PD) patients. Background: Autonomic nervous system dysfunction (AD) is a…
  • MDS Virtual Congress 2020

    Long-term quality of life after subthalamic deep brain stimulation depends on non-motor symptoms in Parkinson’s disease

    S. Jost, L. Timmermann, A. Rizos, M. Silverdale, J. Evans, P. Loehrer, M. Samuel, J. Petry-Schmelzer, A. Sauerbier, M. Barbe, G. Fink, V. Visser-Vandewalle, K. Ashkan, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To predict 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). Background: STN-DBS improves…
  • MDS Virtual Congress 2020

    Functional Hearing Impairment Common In Parkinson’s Disease: Insights From A Pilot Study

    D. Nene, M. Choi, A. Yu, M.S Mirian, J.A Small, L.M Jenstad, S. Appel-Cresswell (Vancouver, BC, Canada)

    Objective: The primary objective of this pilot study was to investigate hearing and its relationship to the neuropsychiatric profile, cognition and quality of life in…
  • MDS Virtual Congress 2020

    Possible correlations between symptoms suggesting gastroparesis and dyskinesias in advanced Parkinson’s disease

    J. Szász, V. Constantin, S. Szatmári, L. Bancu, D. Georgescu, J. Szederjesi, M. Ciorba, A. Racz, I. Mihaly, K. Orbán (Targu Mures, Romania)

    Objective: The objective was to describe the spectrum of gastrointestinal complaints in a large cohort of patients with advanced Parkinson’s Disease (APD), who were repeatedly…
  • MDS Virtual Congress 2020

    Pulmonary function in Parkinson’s disease

    A. O'Callaghan, W. Gray, S. Bourke, R. Walker (North Shields, United Kingdom)

    Objective: To establish if pulmonary function is impaired in Parkinson’s disease (PD) and define any pattern of impairment. Background: Parkinson’s disease (PD) is associated with…
  • MDS Virtual Congress 2020

    WATCH-PD: Wearable Assessments in the Clinic and Home in Parkinson’s Disease: Study Design and Update

    J.L Adams, E.R Dorsey, A. Steinman, T. Kangarloo, R. Alexander, B. Tracey, N. Zach, R. Rubens, M. Kostrzebski, M. Bockus, R. O'Loughlin, E.A Stevenson, J. Cosman (Rochester, NY, USA)

    Objective: To determine whether digital measures can provide a progression profile in early Parkinson’s disease (PD) that is more sensitive and/or less variable than current…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • #24475 (not found)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley